- Quantity number indicates bottle
- 100 ml bottle
Treatment of superficial and deep mycoses: Infections of the skin, hair and nails by dermatophytes and/or yeasts (dermatomycosis, onychomycosis, perionyxes, pityriasis Versicolor, chronic mucocutaneous candidiasis etc. especially when topical treatment is difficult or not very effective, owing to involvement of large skin surfaces or to lesions affecting deeper dermal layers, nails and hairs Yeast infection of the mouth (oral thrush, perleche) and the gastrointestinal tract Vaginal candidiasis, especially chronic recurrent cases or cases responding poorly to topical treatment Systemic mycotic infections such as systemic candidiasis, Para coccidioidomycosis, histoplasmosis, coccidioidomycosis etc. Maintenance treatment to prevent recurrence in systemic mycotic infections and in chronic mucocutaneous candidiasis. Prophylactic treatment to prevent mycotic infection in patients with reduced host defenses, e.g., patients with cancer, organ transplant and burns. Therapeutic Class Drugs for subcutaneous and systemic mycoses Pharmacology Ketoconazole interferes with biosynthesis of triglycerides and phospholipids by blocking fungal CYP450, thus altering cell membrane permeability in susceptible fungi. It also inhibits other fungal enzymes resulting in the accumulation of toxic concentrations of hydrogen peroxide.